Stay updated on AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.

Latest updates to the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page
- CheckyesterdayChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to skin and connective tissue diseases. The previous version's references to specific locations and certain disease resources have been removed.SummaryDifference2%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check22 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check30 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
- Check37 days agoChange DetectedThe web page has updated its version from v2.16.6 to v2.16.8 and now includes information about HHS Vulnerability Disclosure.SummaryDifference0.3%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
Stay in the know with updates to AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.